Crossref
journal-article
Massachusetts Medical Society
New England Journal of Medicine (150)
References
3
Referenced
42
- FDA drug review: postapproval risks, 1976-85. Washington, D.C.: General Accounting Office, April 1990. (GAO/PEMD-90-15.)
10.1001/archinte.165.2.171
10.1001/jama.292.21.2622
Dates
Type | When |
---|---|
Created | 20 years, 5 months ago (March 23, 2005, 6:30 p.m.) |
Deposited | 8 years, 10 months ago (Nov. 2, 2016, 3:42 p.m.) |
Indexed | 1 year, 3 months ago (May 13, 2024, 1:45 a.m.) |
Issued | 20 years, 5 months ago (March 24, 2005) |
Published | 20 years, 5 months ago (March 24, 2005) |
Published Print | 20 years, 5 months ago (March 24, 2005) |
@article{Okie_2005, title={Safety in Numbers — Monitoring Risk in Approved Drugs}, volume={352}, ISSN={1533-4406}, url={http://dx.doi.org/10.1056/nejmp058029}, DOI={10.1056/nejmp058029}, number={12}, journal={New England Journal of Medicine}, publisher={Massachusetts Medical Society}, author={Okie, Susan}, year={2005}, month=mar, pages={1173–1176} }